Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.9751
+0.0326 (3.46%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Immunic Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 35.67 | 46.67 | 106.75 | 86.86 | 127.45 | Upgrade
|
Short-Term Investments | - | - | 9.63 | - | - | Upgrade
|
Cash & Short-Term Investments | 35.67 | 46.67 | 116.37 | 86.86 | 127.45 | Upgrade
|
Cash Growth | -23.58% | -59.89% | 33.97% | -31.85% | 333.97% | Upgrade
|
Other Receivables | 0.68 | 2.48 | 2.66 | 2.15 | 1.64 | Upgrade
|
Receivables | 0.68 | 2.48 | 2.66 | 2.15 | 1.64 | Upgrade
|
Prepaid Expenses | 1.87 | 2.31 | 5.61 | 15.98 | 4.65 | Upgrade
|
Other Current Assets | 1.11 | 1.07 | 1.23 | - | - | Upgrade
|
Total Current Assets | 39.33 | 52.53 | 125.86 | 104.99 | 133.75 | Upgrade
|
Property, Plant & Equipment | 1.54 | 1.77 | 1.85 | 1.1 | 1.1 | Upgrade
|
Goodwill | - | - | - | 32.97 | 32.97 | Upgrade
|
Other Long-Term Assets | - | - | 0.04 | 0.04 | 0.04 | Upgrade
|
Total Assets | 40.87 | 54.3 | 127.75 | 139.1 | 167.86 | Upgrade
|
Accounts Payable | 7.85 | 5.1 | 4.28 | 3.75 | 3.7 | Upgrade
|
Accrued Expenses | 12.91 | 18.66 | 7.99 | 7.07 | 4.32 | Upgrade
|
Current Portion of Leases | 0.74 | 0.7 | 0.57 | 0.41 | 0.3 | Upgrade
|
Other Current Liabilities | 0.68 | 0.27 | 0.24 | 0.18 | 0.08 | Upgrade
|
Total Current Liabilities | 22.18 | 24.73 | 13.08 | 11.4 | 8.4 | Upgrade
|
Long-Term Leases | 0.26 | 0.64 | 0.99 | 0.58 | 0.68 | Upgrade
|
Total Liabilities | 22.44 | 25.37 | 14.07 | 11.99 | 9.08 | Upgrade
|
Common Stock | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 525.61 | 436.06 | 427.93 | 324.24 | 266.82 | Upgrade
|
Retained Earnings | -511.4 | -410.89 | -317.28 | -196.87 | -103.93 | Upgrade
|
Comprehensive Income & Other | 4.21 | 3.76 | 3.04 | -0.25 | -4.11 | Upgrade
|
Total Common Equity | 18.43 | 28.93 | 113.68 | 127.12 | 158.79 | Upgrade
|
Shareholders' Equity | 18.43 | 28.93 | 113.68 | 127.12 | 158.79 | Upgrade
|
Total Liabilities & Equity | 40.87 | 54.3 | 127.75 | 139.1 | 167.86 | Upgrade
|
Total Debt | 1 | 1.33 | 1.56 | 0.99 | 0.98 | Upgrade
|
Net Cash (Debt) | 34.66 | 45.34 | 114.81 | 85.87 | 126.48 | Upgrade
|
Net Cash Growth | -23.55% | -60.51% | 33.70% | -32.10% | 338.41% | Upgrade
|
Net Cash Per Share | 0.35 | 1.02 | 3.61 | 3.63 | 8.07 | Upgrade
|
Filing Date Shares Outstanding | 90.15 | 89.93 | 44.4 | 27.91 | 21.17 | Upgrade
|
Total Common Shares Outstanding | 90.15 | 45.18 | 39.31 | 26.34 | 21.17 | Upgrade
|
Working Capital | 17.16 | 27.81 | 112.79 | 93.59 | 125.35 | Upgrade
|
Book Value Per Share | 0.20 | 0.64 | 2.89 | 4.83 | 7.50 | Upgrade
|
Tangible Book Value | 18.43 | 28.93 | 113.68 | 94.15 | 125.82 | Upgrade
|
Tangible Book Value Per Share | 0.20 | 0.64 | 2.89 | 3.57 | 5.94 | Upgrade
|
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.